Intravenous Iron: Evaluation of the Use of Saccharated Iron Oxide in Iron Deficiency States in Obstetrics and Gynecology

Saccharated iron oxide has been given to 23 patients in doses of 480 to 1,430 mg. Toxic symptoms were minimal. Hematologic response was good in 21 patients. Continued bleeding accounted for the poor response in 2 persons. Saccharated iron oxide is a safe preparation for clinical use. It is easy to administer. Further clinical evaluation is warranted. Excessive amounts of intravenous iron should not be given to any individual.